Manufacturer:

Y-mabs Therapeutics

Name:

DANYELZA

Category:

J Code

HCPCS:

J9348

NDC(s):

73042-0201-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

DANYELZA is a Cancer drug manufactured by Y-mabs Therapeutics and administered via the Intravenous route of administration. The J Code: J9348 is aligned to the drug DANYELZA.